Singapore Medical Group Limited announced unaudited consolidated earnings results for the second quarter and first half ended June 30, 2018. For the quarter, the company reported revenue of SGD 21,595,000 against SGD 16,630,000 for the same period a year ago. Profit before tax was SGD 3,914,000 against SGD 2,811,000 a year ago. Profit attributable to owners of the company was SGD 3,406,000 or 0.73 cents basic and diluted per share against SGD 2,580,000 or 0.60 cents diluted per share for the same period a year ago. Net cash flows generated from operating activities was SGD 4,549,000 against SGD 1,338,000 a year ago. Purchase of property, plant and equipment was SGD 1,383,000 against SGD 630,000 a year ago. The increase in revenue as compared to the same period a year ago, due to Increase in revenue of Health Business segment and Increase in revenue of Diagnostic & Aesthetics Business segment. EBITDA was SGD 5,293,000 against SGD 3,577,000 a year ago. For the first half, the company reported revenue of SGD 40,824,000 against SGD 30,663,000 for the same period a year ago. Profit before tax was SGD 7,675,000 against SGD 4,542,000 a year ago. Profit attributable to owners of the company was SGD 6,827,000 or 1.45 cents diluted per share against SGD 4,012,000 or 1.03 cents basic and diluted per share for the same period a year ago. Earnings per share basic were 1.48 cents against 1.03 cents for the same period a year ago. Net cash flows generated from operating activities was SGD 7,227,000 against SGD 3,964,000 a year ago. Purchase of property, plant and equipment was SGD 2,618,000 against SGD 689,000 a year ago. EBITDA was SGD 10,235,000 against SGD 5,909,000 a year ago.